Packaging ServicesHealth DiagnosticsNutraceuticalStem Cell TherapySurgeryBiotechnologyManufacturingScience and Engineering
Description
Alfresa Holdings Corporation provides a full-line assortment made by all pharmaceutical producers to the customers. The company will proceed with various business developments related to the medical care and healthcare with pharmaceutical wholesaling…
Analysis
Deep value
Alfresa Holdings Corporation looks superficially cheap, but weak underlying metrics raise the question of whether this is value or a trap.
On valuation, the picture is attractive. The owner-earnings multiple stands at 10.9×; owner earnings: the cash an owner could take out each year.
Growth is tepid; the safety picture is sturdy. The company scores 7/20 on our value-creation score: creating some value.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202361
54
2023202420252026
All-time high
77
Mar 2026
All-time low
54
Jun 2026
Average rank
66
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
97
95
97
95
Price/Earnings
78
82
45
76
Price/Book
80
87
78
95
Dividend Yield
69
79
65
82
Value (overall)
96
99
83
99
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.